Medicines For Europe has suggested that the Netherlands’ proposal to transpose the Urban Waste Water Treatment Directive ...
The UK agency confirms an AI center, early access scheme and PCCPs in a push for more adaptive regulation – but industry ...
Among other executive moves are two Roche departures, to Oak Hill Bio and Pharmanovia, and three Moderna departures, to ...
Today marks the start of Global Biosimilars Week 2026, the latest instalment of the annual campaign from the IGBA that this ...
Menarini CEO Elcin Barker Ergun kept Stemline intact, licensed an obesity drug and, with NewAmsterdam, secured the first ...
Innovent’s EGFR/B7H3-targeting bispecific ADC, InSilico’s AI-designed pan-TEAD and Mabwell’s nectin-4–targeting ADC show strengths while seeking global-first status.
The FDA approved the anti-IL6R drug for thyroid eye disease, but drugs targeting IGF-1R are still regarded as the gold ...
Industry groups largely support the FDA’s proposal to let distributed manufacturing networks register as one establishment, ...
The Expert Panel for Cosmetic Ingredient Safety accepted the recommendations for prostaglandin analogues from the Read-Across ...
NervGen's RESTORE trial, which dosed its first patient Oct. 12, is a rare pivotal spinal cord injury study built on the ...
Fresenius Kabi has announced a leadership change that will see Marc-Alexander Mahl take over responsibility of the business ...
Bipartisan House legislation would exempt ostomy and urological supplies from Medicare competitive bidding for five years, as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results